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Introduction {#sec1}
============

For any epithelial cancer to become malignant, it must breach the basement membrane extracellular matrix (ECM) barrier before commencing metastatic invasion. Defects in the basement membrane (BM) accompany local metastatic invasion of murine and human epithelial cancers ([@bib2], [@bib11], [@bib14], [@bib23], [@bib44]). However, from the earliest stages of cancer development, an inflammatory response is triggered by pre-neoplastic cells, and this can drive a proliferative response and trigger subsequent metastatic spread of the cancer ([@bib3], [@bib4], [@bib8], [@bib9], [@bib12], [@bib24], [@bib25]). For inflammatory cells to directly interact with pre-neoplastic cells, they too must breach the basement membrane, but in the reverse direction, from the dermal connective tissue into the epidermis. Similar basement membrane breaching is seen during development ([@bib43]) and also when immune cells diapedese through vessel walls ([@bib49]). The early stages of cancer initiation are difficult to live-image in the opaque tissues of mice and human. However, the translucent zebrafish larvae, in which both pre-neoplastic cells and immune cells can be fluorescently labeled, offer the possibility of visualizing the moments when basement membrane breaching by inflammatory cells occurs.

Here we use inducible models to generate HRAS^G12V^-expressing epidermal pre-neoplastic cells ([@bib37]). This allows us to observe how one oncogene, mosaically expressed in specific cell lineages, can disrupt the local skin architecture and trigger an inflammatory response. We combine these models with a transgenic zebrafish line in which epidermal collagen Iα2 is fluorescently labeled to reveal a meshwork of ECM immediately beneath the basement membrane ([@bib34]), which together we refer to as the basement membrane zone (BMZ) ([@bib33], [@bib36]). Using correlative light and electron microscopy (CLEM), we study precisely how immune cells traverse this barrier to access pre-neoplastic cells in the epidermis at these early cancer stages.

Results and Discussion {#sec2}
======================

Cancer Initiation in Different Cell Lineages Causes Local Disruption of the Skin Architecture {#sec2.1}
---------------------------------------------------------------------------------------------

In contrast with adult mammalian skin, larval zebrafish skin consists of only two epithelial cell layers, the outer superficial epidermal cell layer and the inner basal epidermal cell layer, the latter tethered to the basement membrane (largely consisting of collagen IV and laminin) ([@bib20]) by hemi-desmosomal junctions ([@bib10], [@bib28]). Directly beneath the basement membrane there is a further layer of ECM largely consisting of collagen I (depicted in [Figure 1](#fig1){ref-type="fig"}A). To analyze normal healthy skin architecture in larvae, we crossed lines expressing cytoplasmic GFP in superficial epidermal cells ([@bib15], [@bib21]) with those expressing tdTomatoCAAX in basal cells ([@bib29], [@bib34]) ([Figures 1A, 1A′, and 1A′](#fig1){ref-type="fig"}′). Scanning electron microscopy reveals the polygonal, pavement-like pattern of superficial cells, with orifices where goblet cells, mucous-secreting cells of wet epithelium, are visible at their interfaces ([Figure 1A′](#fig1){ref-type="fig"}″).Figure 1Zebrafish Skin Cancer Models and Immune Cell Recruitment(A) WT 3 dpf larval skin: superficial cell layer (dark gray in A, GFP \[green\] in A′ and A″) and basal cell layer (light gray in A, magenta in A″) with underlying basement membrane (BM).(A″′) Scanning electron microscopy shows a goblet cell (arrow in A and A″′, green in B) in the epidermis.(B) kita:RAS model. HRASG12V-GFP expressing goblet cells in 7 dpf larva over-proliferate (green in B, B′, and B″). Basal cells are in magenta (B″). Tracks of goblet cells by scanning electron microscopy (B″′).(C and D) K4:RAS and K19:RAS models. HRASG12V-GFP expression (48 h postinduction \[hpi\] of 4OHT) in superficial (C and C′) or basal (72 hpi) (D and D′) pre-neoplastic cells is shown in green.(C) HRASG12V-GFP-expressing superficial clones (basal cells shown in magenta) in 3 dpf larva (asterisk, C″) and scanning electron microscopy (72 hpi) (C″′).(D) HRASG12V-GFP-expressing basal clones in 5 dpf larva (superficial cells in magenta) (asterisk in D″ and scanning electron microscopy in D″′).(E--H) Mosaic expression of oncogenic HRASG12V in skin cells compared with control GAP-43 GFP expression results in recruitment of neutrophils (magenta; E) and macrophages (red; F) 48 hpi, quantified in (G) and (H), respectively. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.(I) Knockdown of both neutrophils and macrophages (with PU.1 and granulocyte colony stimulating factor \[GCSF\] MOs) inhibits superficial pre-neoplastic cells growth (GFP) in 48 hpi larvae.Scale bars: 100 μm (A′, A″, B′, B″, C′, C″, D′, D″, E, F, and I); 20 μm (A″′, B″′, C″′, and D″′). Graphs display mean ± SEM.

To study events during cancer initiation in skin, we used three models to express HRAS^G12V^ under different promoters: the *kita* promoter drives expression in melanocytes and goblet cells ([Figure 1](#fig1){ref-type="fig"}B) ([@bib41]) (model referred to as kita:RAS), the *keratin4* promoter drives expression in superficial cells (K4:RAS) ([@bib37]) ([Figure 1](#fig1){ref-type="fig"}C), and the *krtt1c19e* promoter drives expression in basal cells (K19:RAS) ([Figure 1](#fig1){ref-type="fig"}D). All three models make use of the gal4-UAS system, and two are 4-hydroxytamoxifen (4OHT) inducible for temporal control of mosaic HRAS^G12V^-GFP expression ([@bib37]). We observe how clones of each of these HRAS^G12V^-GFP-expressing lineages disrupt normal skin architecture: kita:RAS leads to proliferation of goblet cells ([Figure 1](#fig1){ref-type="fig"}B) sitting within the *tdTomato*-expressing basal cell layer ([Figure 1B′](#fig1){ref-type="fig"}′). Scanning electron microscopy shows how these proliferating goblet cells disturb the otherwise continuous superficial epidermal layer ([Figure 1B′](#fig1){ref-type="fig"}″). By comparison, mosaic expression of K4:RAS ([Figures 1C′ and 1C′](#fig1){ref-type="fig"}′) results in superficial cell clones that are more disruptive, leading to a general mixing of epithelial cells between their two originating layers ([Figure 1C′](#fig1){ref-type="fig"}′). Scanning electron microscopy images show considerable disorganization and protruding cells ([Figure 1C′](#fig1){ref-type="fig"}″). Similarly, pronounced disorganization of the skin is apparent in the K19:RAS model ([Figures 1D′ and D′](#fig1){ref-type="fig"}′), where both basal cells and superficial cells protrude, confirmed by scanning electron microscopy ([Figure 1D′](#fig1){ref-type="fig"}″).

Pre-neoplastic Skin Cells Recruit High Numbers of Innate Immune Cells That Are Essential for Their Growth {#sec2.2}
---------------------------------------------------------------------------------------------------------

Pre-neoplastic kita:RAS cells in larval zebrafish skin lead to an inflammatory response ([@bib8], [@bib12]). We found an increased recruitment of both neutrophils and macrophages to HRAS^G12V^-expressing clones in both superficial and basal cell models also by 48 h postinduction (48 hpi) ([Figures 1](#fig1){ref-type="fig"}E and 1F; [Figure S1](#mmc1){ref-type="supplementary-material"}), quantified in [Figures 1](#fig1){ref-type="fig"}G and 1H (superficial) and [Figure S1](#mmc1){ref-type="supplementary-material"} (basal). To investigate the significance of inflammatory cell recruitment, we performed morpholino (MO)-mediated knockdown of neutrophils and macrophages ([@bib9]). A combination of pu.1 ([@bib39]) and gcsfr1 ([@bib31]) MOs results in a significant decrease in pre-neoplastic cell growth ([Figure 1](#fig1){ref-type="fig"}I). Examination of transmission electron microscopy (TEM) sections from each cancer model revealed morphologically distinct innate immune cells within or in the vicinity of pre-neoplastic clones ([Figures 2](#fig2){ref-type="fig"}Aii--2Aiv), whereas away from pre-neoplastic cells, immune cells in the epidermal layer were very rare ([Figure 2](#fig2){ref-type="fig"}Ai), supporting our light microscopy imaging and quantification ([Figures 1](#fig1){ref-type="fig"}E--1H; [Figure S1](#mmc1){ref-type="supplementary-material"}).Figure 2Correlative Light and Electron Microscopy of Immune Cells Entering the Epidermis(Ai) Transmission electron microscopy (TEM) of 5 dpf WT larval skin; superficial epidermal layer (sepia), basal layer beneath, and the basement membrane, visible as a thin dark line (arrowheads) and goblet cell. (ii) TEM of kita:RAS clone (16 dpf), and superficial (iii) and basal (iv) clones in 5 dpf (72 hpi) larvae, shows immune cells (false colored red) within the clones.(Bi) TEM of larval BMZ. Red arrows indicate the basement membrane; the white bar indicates collagen I, E is the epidermis above, and D is the dermis below the BMZ. (ii and iii) CLEM; confocal image (ii, lower left) and methylene blue-stained section (ii, right) show where clone and immune cell interactions take place (yellow boxes) near the cloaca (arrow in ii). (iii) Granulocyte (red) in a breach in the BMZ (green) beneath a goblet cell clone (see inset) in 10 dpf larva.(C) Neutrophil (red) protrusions surrounding bundled collagen I (asterisk) below the BM (arrowheads) beneath a pre-neoplastic superficial cell clone (in inset BM zone is colored in green) in 5 dpf (72 hpi) larva.(Di) A macrophage (red), containing collagen, spans a breach in the BM (green) beneath a basal cell clone in 5 dpf (72 hpi) larva. (ii) High-magnification view corresponding to yellow box in red inset, which, in turn, corresponds to red box in (i). Red arrowheads indicate collagen fibrils.(E) Confocal imaging of a 5 dpf/48 hpi larva shows a macrophage (red, see white arrow) above the collagen I layer (green) approaching two pre-neoplastic basal cells (red, see white asterisks).(F) Confocal imaging of a macrophage (white arrows) containing engulfed collagen (yellow) in the collagen I-GFP layer in 5 dpf (48 hpi) larva. Inset: a single z stack shows collagen I-GFP (yellow) within the macrophage.(G) Stills from a time-lapse video (minutes in top right corner) show a macrophage (red) squeezing through a pre-existing hole in the collagen I layer (green) beside a superficial pre-neoplastic clone on the left (red, dotted white circle) in 5 dpf (72 hpi) larva. See also [Video S1](#mmc2){ref-type="supplementary-material"}.Scale bars: 5 μm (Ai--Aiv, Biii and C \[insets\], Di, and G \[video stills\]); 500 nm (C); 100 nm (Dii); 1 μm (Dii \[inset\] and Biii); 10 μm (E and F); 20 μm (G); 500 nm (Bi); and 100 μm (Bii).

Capturing Immune Cells as They Traverse the Basement Membrane Zone to Access Pre-neoplastic Skin Cells {#sec2.3}
------------------------------------------------------------------------------------------------------

Both light and TEM data described above indicate that innate immune cells make direct contact with pre-neoplastic cells in the larval skin. However, it is unclear how they gain access to these cells because they are separated by the BMZ matrix barrier ([Figure 2](#fig2){ref-type="fig"}Bi). By fixing larvae when our live-imaging studies indicate that immune cells have arrived at a clone of pre-neoplastic cells, we can perform CLEM to capture instances where immune cells have just breached the BMZ directly beneath HRAS^G12V^-expressing clones ([Figures 2](#fig2){ref-type="fig"}Bii and 2Biii). We also observe immune cells with bundled collagen between cell protrusions suggesting collagen degradation at the BMZ ([Figure 2](#fig2){ref-type="fig"}C). And we also show immune cells spanning a breach through the BMZ beneath a pre-neoplastic basal cell clone ([Figure 2](#fig2){ref-type="fig"}Di). TEM indicates examples of encapsulated collagen fibrils within breaching macrophages ([Figure 2](#fig2){ref-type="fig"}Dii). The epidermal-derived interstitial collagen I of the BMZ can be distinguished by confocal imaging of a collagen I-GFP-transgenic fish ([@bib34]), where collagen I-GFP is expressed under the control of the basal epithelial cell-specific promoter K19. We crossed this collagen I-GFP-transgenic fish with one expressing mCherry in macrophages and mosaically induce HRAS^G12V^ in basal ([Figure 2](#fig2){ref-type="fig"}E) or superficial ([Figure 2](#fig2){ref-type="fig"}G) cells. Lateral view images from a video of such larvae reveal macrophages containing collagen I-GFP as they move through the collagen I layer ([Figure 2](#fig2){ref-type="fig"}F, inset). Macrophages "sit" for periods of up to 120 min within the matrix layer ([Figure 2](#fig2){ref-type="fig"}F).

Interestingly, confocal imaging of the collagen I layer in the vicinity of pre-neoplastic superficial clones also reveals occasional small pre-existing holes near the clone ([Figure 2](#fig2){ref-type="fig"}G). We captured macrophages traversing through such pre-existing holes ([Figure 2](#fig2){ref-type="fig"}G; [Video S1](#mmc2){ref-type="supplementary-material"}) as they gain access to the epithelial layer; strikingly, these traverses are rapid, taking between 5 and 30 min, which is faster than the time required for active degradation of the matrix ([@bib40]). These pre-existing holes were presumably generated previously, either proteolytically or mechanically, and subsequently used by immune cells as a route through the basement membrane to reach the epidermis. A similar "tunneller and follower cell" scenario is described for cancer-associated fibroblasts (CAFs) as they proteolytically degrade matrix providing a route for cancer cells to metastasize ([@bib13]), and also may enable xenografted cancer cell migrations as neutrophils first deform collagen matrix in the vicinity of larval zebrafish cancer explants ([@bib18]). A recent *in vitro* study describes immune cells sampling their vicinity for large pores in the matrix, allowing them to choose paths of least resistance ([@bib38]). The rapidly traversed holes we observe occasionally remain open but sometimes shrink in size after the immune cell has passed through ([Figure 2](#fig2){ref-type="fig"}G). The speed of traversing may explain why we so rarely capture these short windows of opportunistic migratory activity.

Video S1. Capturing the Minutes as a Macrophage Opportunistically Squeezes through an Already Established Hole in the Collagen I Matrix (Green) Layer of the BMZ, Related to Figure 2G

To investigate the importance of proteolytic degradation of the BMZ by immune cells to access epidermal pre-neoplastic clones, *in vivo* "zymography" studies visualized local matrix metalloproteinase (MMP) activity ([@bib48]). Highly de-quenched (DQ) fluorescein-labeled gelatin was injected into the flank of 3 days postfertilization (dpf) larvae, and fluorescence resulting from degradation of the gelatin was observed at the leading edges of macrophages, suggesting MMP activity by these cells ([Figure 3](#fig3){ref-type="fig"}Ai and 3Aii) that can be blocked by MMP inhibitor GM6001 ([Figure 3](#fig3){ref-type="fig"}Aiii and 3Aiv). Treatment of larvae with GM6001 inhibits neutrophil migration to tail fin wounds as described previously ([@bib17]) ([Figure 3](#fig3){ref-type="fig"}B); however, the same treatment did not inhibit immune cell recruitment to pre-neoplastic cells ([Figure 3](#fig3){ref-type="fig"}C). Similar is true for larvae treated with a pan-protease inhibitor cocktail or a neutrophil elastase inhibitor (Sivelestat) ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). These data suggest that although immune cells may be able to proteolytically burrow through the matrix, they can also traverse in ways that are independent of proteolysis. Indeed, T cells move in an amoeboid fashion through a 3D matrigel substrate, pushing pseudopodial extensions through pre-existing collagen gaps, if proteolysis is blocked ([@bib51]). Similarly, in a 3D *in vitro* model of carcinoma, CAFs were shown to remodel and soften the matrix between themselves and human colon cancer cells enabling cancer cell invasion, also in a protease-independent fashion ([@bib14]).Figure 3Weak Spots in the BM Barrier Layer Allow Opportunistic Crossing of Immune Cells into the Epidermis(A) De-quenched fluorescein isothiocyanate (FITC)-gelatin in 3 dpf larva indicates MMP activity (green or yellow) at the leading edge of macrophages (red; i and ii). GM6001 inhibits MMP activity in whole somite (iv versus iii).(B) GM6001 inhibits neutrophil recruitment to tail fin wound, but does not inhibit neutrophil (magenta) or macrophage (red) recruitment to pre-neoplastic cells in 3 dpf (24 hpi) larvae (C). See also [Figures S2](#mmc1){ref-type="supplementary-material"}A and [S2](#mmc1){ref-type="supplementary-material"}B.(D) Neutrophils and macrophages preferentially move along the horizontal myoseptum (indicated with arrowheads) in wild-type 5 dpf larval skin. See also [Figures S2](#mmc1){ref-type="supplementary-material"}C and [S2](#mmc1){ref-type="supplementary-material"}D.(E) Collagen along the horizontal myoseptum of 5 dpf larva shows altered structure and gaps or weak spots (i and ii). Higher-magnification view illustrates variation in size of gaps along the horizontal myoseptum (iii, white arrowheads). See also [Figure S2](#mmc1){ref-type="supplementary-material"}E.(Fi) Immunostaining of collagen I (green) and collagen IV (red) at the epidermal (E) dermal (D) interface (a) reveals concomitant holes in collagen IV (b) and collagen I (c) along the horizontal myoseptum of 5 dpf larvae. (ii) TEM of 5 dpf WT larval skin shows a gap through the BMZ at the horizontal myoseptum (yellow arrow in a). Red arrowheads indicate the margins of the BM gap; black arrows define margins of disrupted collagen I in the same location (b).(G) Macrophages (red, 14 dpf) and neutrophils (magenta, 5 dpf) crawling adjacent to collagen I fiber "tracks" (gray).(H) Schematic and quantification of neutrophils and macrophages within the flank of 3 dpf larvae.(I) Still series from a video shows neutrophil (magenta) migrating along the protruding collagen I fibers (gray) at the myosepta (arrowhead) in 5 dpf larva. See also [Video S2](#mmc3){ref-type="supplementary-material"}.(J) Neutrophil (magenta) squeezes (arrow) through collagen I at myoseptum in a larva 14 dpf.Scale bars: 10 μm (Ai, Aii, Fib, and Fic); 20 μm (Aiii, Aiv, Ei, Eii, G, and J); 5 μm (Eiii, Fia, and Fiia); 50 μm (B, C, D, and I); 400 nm (Fiib). Graphs display mean ± SEM.

Opportunistic Access to the Epidermis by Immune Cells Is through Pre-existing "Weak Spots" along the Horizontal Myoseptum and Leads to Bigger Clones of Pre-neoplastic Clones Locally {#sec2.4}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In order to better understand how immune cells traverse the BMZ in a protease-independent manner, we investigated how the few neutrophils and macrophages in wild-type (WT) larval skin gain access to the epidermis. Live imaging of otherwise WT, collagen I-GFP larvae with fluorescently labeled neutrophils and macrophages reveals protruding collagen I fibers along the horizontal and vertical myosepta, which may provide a preferred route for immune cell migration ([Figure 3](#fig3){ref-type="fig"}D; [Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D; and quantified in [Figure 3](#fig3){ref-type="fig"}H). High-resolution imaging of fibrils shows disruptions in collagen organization, leaving weak spots in the collagen I layer; on average we see two "holes" per somite, ranging from 1 to 4 μm in diameter ([Figure 3](#fig3){ref-type="fig"}E) in all larvae examined and in older fish also along the transverse myosepta ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Co-immunostaining of collagen I-GFP and endogenous collagen IV (the main component of the lamina densa of the basement membrane) shows a co-incidence of holes (of 17 collagen I holes analyzed, 15 show a clear concomitant collagen IV disruption), supporting the use of the transgenic (Tg) collagen I-GFP fish as a tool to live-image the BMZ and as a proxy for indicating breaches through the matrix barrier layers ([Figure 3](#fig3){ref-type="fig"}Fi). TEM studies also show co-incidental disruption of the BMZ collagen I matrix and the BM itself ([Figure 3](#fig3){ref-type="fig"}Fii). We observe collagen I fibers protruding down into the tissue along the myosepta, partitioning the developing myotomes, and possibly confining innate immune cells to "highways" leading them along regions where the BMZ has weak spots ([Figures 3](#fig3){ref-type="fig"}G, 3I, and 3J; [Video S2](#mmc3){ref-type="supplementary-material"}; [Figure S2](#mmc1){ref-type="supplementary-material"}D).

Video S2. Neutrophils (Purple) Moving along the Underside of Collagen I Matrix (Gray) Layer of the BMZ, Apparently Guided by Myoseptal Fibrils Tracks, Related to Figure 3I

If these ready-made holes provide favored sites where immune cells can access the epidermis, one might expect that clones of pre-neoplastic cells lying in close proximity to the horizontal myoseptum would be at a competitive advantage for immune cell visits, and consequently for the trophic signals that these cells deliver. Indeed, there are significantly more neutrophil contacts with clones at the midline compared with clones located in adjacent regions ([Figure 4](#fig4){ref-type="fig"}A), and clones grow faster along the midline ([Figure 4](#fig4){ref-type="fig"}B). To quantify this, we compared the proliferation of pre-neoplastic cells in clones near to the midline versus more distant clones by performing 5-ethynyl-2′-deoxyuridine (EDU) staining of HRAS^G12V^-expressing basal skin cells. In control larvae, the number of proliferating cells is equally distributed across the flank, but in HRAS^G12V^-expressing larvae, proliferation is increased in clones along the midline of the fish. This supports the concept that pre-neoplastic clones in close proximity to the horizontal myoseptum receive more immune cell visits driving increased proliferation ([Figure 4](#fig4){ref-type="fig"}C).Figure 4Immune Cells Access Epidermal Clones through Portals in the Basement Membrane(A) Neutrophil and pre-neoplastic cell contacts (asterisks) along the horizontal myoseptum compared with elsewhere in the flank 8 hpi, over a 3-h period.(B) Proliferation of clones (asterisk) along the horizontal myoseptum compared with clones farther away (arrowheads).(C) Example of EDU staining of control, GFPCAAX-expressing basal cells (left) versus GFP-expressing HRASG12V basal cells (right) at 18 hpi. Quantification of double EDU (red) and GFP +ve cells in indicated zones: A, B, and C.(D--G) Degradation of the BMZ beneath later stage pre-neoplastic cell clones.(Di) A superficial HRASG12V-expressing clone (red) on collagen I-GFP with holes in the collagen I layer immediately beneath the clone (white dotted circle, Dii) in a larva 6 dpf (96 hpi).(E) Degraded collagen I-GFP zone beneath a large HRASG12V-expressing superficial clone (red) in a larva 5 dpf (96 hpi; white dotted line in Eii). Lumps of collagen I within the pre-neoplastic cells are outlined (red dotted line).(Fi) A transverse 3D view of the clone along dotted line A in (Ei). GFP-collagen I within pre-neoplastic cells (asterisks and inset in Fi). See also [Figures S3](#mmc1){ref-type="supplementary-material"}A and [S3](#mmc1){ref-type="supplementary-material"}B. 3D view of clone along dotted line B in (Ei) shows invasion of the clone through the collagen I-GFP layer in (Fii).(G) TEM shows BMZ degradation (white arrowheads) beneath a large HRASG12V-expressing superficial cell clone (120 hpi) in 6 dpf larvae. See also [Figure S3](#mmc1){ref-type="supplementary-material"}C.(H) Maximal projection confocal image of a flank wound in a larva 7 dpf, 2 days postinjury, shows a defect in the collagen I-GFP layer and recruited macrophages (red). 3D projection shows macrophages (red) below and above the matrix breach.(I) CLEM shows breach (arrowheads) in the BMZ (green) with invading immune cells (purple nuclei).(Ji) Neutrophils (magenta) escaping the wound (arrowheads) and crawling over collagen I layer toward pre-neoplastic superficial clone (dotted circle) as indicated by neutrophil tracks in (Jii).See also [Figure S4](#mmc1){ref-type="supplementary-material"}. Scale bars: 50 μm (A--C, H, and J); 10 μm (D and I); 30 μm (E); 1 μm (G), 5 μm (G inset). Graphs display mean ± SEM.

Collagen Uptake by Larger Pre-neoplastic Clones or Mechanical Damage to the Skin Generates Further, More Extensive BMZ Breaches {#sec2.5}
-------------------------------------------------------------------------------------------------------------------------------

The regions of the BMZ beneath growing clones of pre-neoplastic cells are of considerable interest because these are the regions where the BM becomes eroded on tumor invasion. In the larval cancer models, as pre-neoplastic clone diameter increases to 30--50 μm, individual holes beneath them begin to coalesce ([Figure 4](#fig4){ref-type="fig"}D). As clone diameters increase to greater than 100 μm, large patches with missing collagen extend beneath them ([Figure 4](#fig4){ref-type="fig"}E). Associated with this matrix loss, collagen I-GFP (which is expressed only by basal epithelial cells) is observed, not only within immune cells, but also within the superficial pre-neoplastic cells ([Figure 4](#fig4){ref-type="fig"}F, inset; [Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B), suggesting active engulfment of matrix, which might affect cancer cell behavior ([@bib5]), but which also provides a further potential route for epidermal access by immune cells. TEM of larvae with bigger pre-neoplastic clones confirms this missing or disrupted BM ([Figure 4](#fig4){ref-type="fig"}G; [Figure S3](#mmc1){ref-type="supplementary-material"}C). Unsurprisingly, these larger clones, where areas of the BM are missing, are most frequently located along the horizontal myoseptum (80% of these clones in 30 fish lie on the horizontal myoseptum) ([Figures 4](#fig4){ref-type="fig"}E and 4G; [Figure S3](#mmc1){ref-type="supplementary-material"}C), suggesting that at sites where there is a pre-existing altered or weakened matrix barrier, there is an increased likelihood of subsequent cancer invasion.

Importantly, damage to the epidermis, for example, resulting from diagnostic needle biopsy of patients or surgery, will generate matrix breaches of considerable size and duration. We have previously shown that tissue damage impacts on the inflammatory response to clones of pre-neoplastic cells in the vicinity of a wound through release of inflammatory cell attractants ([@bib1]), and there is considerable literature on how wounding may exacerbate cancer progression ([@bib26], [@bib42], [@bib46]). By wounding collagen I-GFP fish, we observe how such a lesion results in a significant breach in the matrix barrier layer, and thus provides another large routeway for immune cells to access the epidermis ([Figure 4](#fig4){ref-type="fig"}H; [Figure S4](#mmc1){ref-type="supplementary-material"}). CLEM of such wounds reveals invading immune cells accessing the epidermis at the wound margin ([Figures 4](#fig4){ref-type="fig"}H and 4I). Live-imaging studies of wounded larvae suggest that although both neutrophils and macrophages can access and enter the epidermis at these ECM barrier breaches, largely only neutrophils progress onward to migrate beyond the wound margin toward pre-neoplastic cells ([Figure 4](#fig4){ref-type="fig"}J) ([@bib1]). We propose that wound-mediated recruitment of immune cells and their subsequent impact on nearby pre-neoplastic cells is not only a consequence of damage attractants, but also because tissue damage provides a large portal through the ECM barrier for immune cells to gain direct access to cancer cells.

Our observations indicate that there may be multiple ways for neutrophils and macrophages to traverse the basement membrane barrier to access pre-neoplastic cells in the epidermis. Proteolytic degradation of matrix is not essential because there are pre-existing, naturally occurring weak spots in the ECM barrier that act as opportunistic portals for immune cells to move from connective tissue into the epidermis; in healthy skin these portals are used for immune surveillance ([Figure S4](#mmc1){ref-type="supplementary-material"}). These weak spots in the BMZ beneath the larval epidermis share similarities with the pattern of matrix distribution around postcapillary venules, where low expression regions are the preferential sites for immune cell extravasation or diapedesis through the vessel wall ([@bib49]). In embryonic tissues, breakdown of the BM enables, and even directs, important cell migrations, as, for example, anchor cell migration leading to fusion with vulval cells in *C. elegans* ([@bib43]), and these developmental invasions may share mechanisms with cancer cell invasion. Previous studies highlight the usefulness of zebrafish as a model to study human BM diseases ([@bib7], [@bib30]) and have characterized and compared BM components between mammals and zebrafish ([@bib35], [@bib36]). Our observations in larval tissues will need verification in adult mammalian tissues in order to be of clinical relevance, but, for example, microperforations in the basement membrane of the bronchial airway and small intestine have previously been described ([@bib19], [@bib47]), and in pathological conditions such as inflammatory bowel disease these may become the precursors of portals for immune cell influx into tissues that, in turn, often precede malignancy ([@bib32], [@bib45]).

Our data show that immune cells can take advantage of the easiest routes through the barrier ECM to access the epithelium in which pre-cancer cells reside. These portals may be small, in otherwise undamaged BM, or larger gaps that are generated as a consequence of cancer erosion or biopsy or surgical wounding, and we show that this access of immune cells to cancer cells is rate limiting for cancer progression ([Figure S4](#mmc1){ref-type="supplementary-material"}). Further studies of these various portals will highlight their usefulness as potential biomarkers for likely cancer progression and as therapeutic targets for cancer prevention.

STAR★Methods {#sec3}
============

Key Resources Table {#sec3.1}
-------------------
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Contact for Reagent and Resource Sharing {#sec3.2}
----------------------------------------

Further information and requests for resource and reagents should be directed and will be fulfilled by the Lead Contact, Paul Martin (<Paul.Martin@bristol.ac.uk>).

Experimental Model and Subject Details {#sec3.3}
--------------------------------------

### Zebrafish husbandry {#sec3.3.1}

Adult zebrafish (*Danio rerio*) were maintained as previously described ([@bib50]). All experiments were conducted with local ethical approval from the University of Bristol and in accordance with UK Home Office regulations (Guidance on the Operations of Animals, Scientific Procedures Act, 1986). All zebrafish lines are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. Our collagen lines were crossed onto a Casper background to prevent auto-fluorescence from melanocytes during confocal imaging. To induce mosaic HRAS^G12V^ expression in the collagen lines, Tg*(krt19:col1α2-GFP;mpeg:mCherry)* fish were crossed with Tg*(6xUAS:mCherry-HRAS*^*G12V*^*)* fish to make the final Tg*(krt19:col1α2-GFP;mpeg:mCherry;UAS:mCherry-HRAS*^*G12V*^*)* transgenic line. These fish we then outcrossed with Tg*(krt19:col1α2-GFP, mpeg:mCherry)* to generate homozygous collagen I-GFP-expressing larvae which we subsequently microinjected with *krt4:KalTA4-ER*^*t2*^ or *krt19:KalTA4-ER*^*t2*^ and treated with 4-hydroxytamoxifen (4OHT), as described below, to induce mosaic HRAS^G12V^-expression in either superficial or basal cells respectively.

Method Details {#sec3.4}
--------------

### Microinjection {#sec3.4.1}

To generate krt4-superficial or krt19-basal mosaic cancer lines, 12.5 to 25ng of *pTol2-krt4:KalTA4-ERT2;cmlc2:eGFP* or *pTol2-krt19:KalTA4-ERT2;cmlc2:eGFP* was injected together with 50ng/μl of purified capped Tol2 mRNA into 1 cell-stage Tg(*UAS:RAS*^*G12V*^*-GFP*) embryos as described previously ([@bib37]). Injected larvae were subsequently treated with 5 μM 4OHT (Sigma-Aldrich, T176) to induce mosaic HRAS^G12V^ expression in either superficial or basal cells. The length of time of expression of HRAS^G12V^ can be controlled and is described in terms of hours post induction (hpi).

### Constructs {#sec3.4.2}

*pTol2-UAS:RAS*^*G12V*^*-mCherry;cry:CFP* was made using the modular MultiSite Gateway cloning strategy, cloning the 6xUAS 5E vector (kind gift from Dr. Dirk Sieger, Edinburgh), mcherry-HRAS^G12V^ ME vector and polyA 3E vector into pDestTol2CG vector from the zebrafish Tol2kit ([@bib27]) that contains a *cry:eCFP-pA* to enable F0 screening. *pTol2-krt19:KalTA4-ERT2;cmlc2:eGFP* was made as described previously for *pTol2-krt4:KalTA4-ERT2;cmlc2:eGFP* ([@bib37]), using the krt19 promoter.

### Generation of Tg(6xUAS:mCherry-HRASG12V) larvae {#sec3.4.3}

12.5 to 25ng of *pTol2-UAS:HRASG12V-mCherry;cry:CFP* construct together with 50ng/μl purified capped Tol2mRNA was injected into one cell stage Casper embryos. Injected larvae were screened for CFP positive eyes at 3-5dpf by fluorescent microscopy and F1 fish were screened for germline transmission. Positively identified founder fish were grown to adulthood and F2 generations were crossed to Et(*kita:GalTA4,UAS:mCherry*) fish to check for mCherry-expressing HRASG12V goblet cell clones. Additionally, these fish were used for microinjection of *krt4:KalTA4-ER*^*t2*^ or *krt19:KalTA4-ER*^*t2*^ to mosaically induce mCherry-expressing superficial or basal cell clones, and crossed onto Tg(*krt19:col1α2-GFP;mpeg:mCherry*) fish for live imaging of macrophage movement in relation to collagen I in response to pre-neoplastic skin cell growth.

### Morpholino experiments {#sec3.4.4}

All morpholinos were obtained from GeneTools LLC. Morpholinos were suspended in distilled water to a concentration of 1mM. 0.5nl drops of 0.25 μM *pu.1* + *gcsfr* MO were injected into one-cell stage Tg*(UAS:RAS*^*G12V*^*-GFP)* embryos together with 25 ng of *krt4:KalTA4-ER*^*t2*^, to knockdown both neutrophils and macrophages and to simultaneously induce mosaic HRAS^G12V^ expression in superficial cells.

The following morpholinos were used: *pu.1* 5′- GATATACTGATACTCC ATTGGTGGT-3′ ([@bib39]) and *gcsfr* 5′-AATGTTT CGCTTACTTTGAAAATGG-3′ ([@bib31]).

### Wounding {#sec3.4.5}

2dpf tg(*UAS:RAS*^*G12V*^*-GFP;lyz:dsRed)* larvae were treated with 10 μM GM6001 or DMSO for 48 hr. At 4dpf a tail fin wound was made with a sterile scalpel at the level of the posterior edge of the notochord. Fish were imaged between 5-6hrs post wounding and analyzed for neutrophil recruitment. Experiments were performed blinded ([Figure 3](#fig3){ref-type="fig"}B).

Four days post fertilization larvae were wounded with a 30G hypodermic needle on their flank either directly above the cloaca or, if there was a pre-neoplastic clone nearby, further away from the clone to prevent wounding of the clone itself. Recruitment of neutrophils was imaged 1 day post wounding (dpw) and recruitment of macrophages at 2dpw ([Figures 4](#fig4){ref-type="fig"}H--4J).

### Drug treatments {#sec3.4.6}

*krt4:KalTA4-ER*^*t2*^ or *krt19:KalTA4-ER*^*t2*^ microinjected larvae were treated with 5 μM 4-hydroxytamoxifen (Sigma-Aldrich, T176) at either 1dpf or 2dpf between 24 and 120hours depending on the experiment. For recruitment of neutrophils and macrophages to pre-neoplastic cells, larvae were treated for 48hrs at 1dpf ([Figures 1](#fig1){ref-type="fig"}E--1I; [Figure S1](#mmc1){ref-type="supplementary-material"}). To initiate larger pre-neoplastic clones, larvae were treated from 2dpf between 72 and 120hrs ([Figures 2](#fig2){ref-type="fig"}G and [4](#fig4){ref-type="fig"}D--4G). For quantifications of neutrophil contacts, larvae were treated for 8hrs and for EDU experiments, larvae were treated for 18hrs.

10 μM GM6001 (Millipore, CC1010) was either co-injected in the flank of 3dpf larvae with FITC-gelatin (AnaSpec, AS-85145) ([Figure 3](#fig3){ref-type="fig"}A) or 2dpf larvae were pre-treated with 10 μM GM6001 or DMSO by immersion 24hrs before 4-OHT treatment (to prevent MMP production before immune cells are drawn to the epidermal pre-neoplastic cells) and subsequently for another 24hrs together with 4-OHT and imaged at 4dpf ([Figure 3](#fig3){ref-type="fig"}C). The same treatment was performed on the siblings for control tail fin wounding experiments as described above ([Figure 3](#fig3){ref-type="fig"}B). The same time frame of treatment was used for treatment with 200 μM Sivelestat (Tocris, 3535) and the phosphatase inhibitor mix consisting of: 100 μM (L-3- trans-carboxyoxirane-2-carbonyl)-l-leucine (3-methylbutyl) amide (E64c; Caymen Chemical), 0.04 TIU/ml Aprotinin (Tocris), 6 μM Leupeptin (Tocris) and 2 μM Pepstatin A (Tocris). Imaging and quantification of all the experiments were performed blinded.

### Transmission electron microscopy/Scanning electron microscopy {#sec3.4.7}

Fish larvae were anaesthetised in 0.01 mg/ml tricaine, and embedded in 1% low melting point agarose bathed in 0.01 mg/ml tricaine in Danieau's buffer after setting. For CLEM studies, larvae that had clones in the vicinity of the cloaca, which was selected as a morphological marker that can be seen pre and post processing, were selected and confocal images taken. After imaging, larvae were removed immediately from agarose and transferred to primary fix (4% glutaraldehyde, 1% paraformaldehyde, 0.05M sodium cacodylate, pH 7.4, 1 mM MgSO4, 1% sucrose) at 4°C overnight. Fixed samples were washed in 0.1M sodium cacodylate (3x10mins) and then secondary fixed in 2% osmium tetroxide, 0.1M sodium cacodylate at room temperature for 2 hours. After fixation, samples were washed 3x10 mins in 0.1M sodium cacodylate and then 2x10mins in dH~2~0 before serial dehydration in EtOH, 30 mins per EtOH concentration. Dehydration was completed by incubation in propylene oxide (PPO; 3 × 20 min). PPO was replaced with a 50:50 mix of PPO:epon, incubated overnight, and then evaporated off for 2 h. Samples were transferred twice to fresh epon (3 g TAAB 812 Resin, 2 g dodecenyl succinic anhydride, 1.25 g methyl nadic anhydride, and 0.1875 g benzyl dimethylamine) for 24 h and then embedded/polymerized at 60°C for 72 h. Sections were cut on an Ultramicrotome (Leica EM UC6) and imaged using a Tecnai 12-FEI 120-kV BioTwin Spirit Transmission Electron Microscope with a FEI Eagle 4k × 4k charge-coupled device camera. Manual image segmentation and false coloring was done using Adobe photoshop.

For SEM, samples were processed almost as for TEM except the fix mixtures: fix 1 was 2.5% glutaraldehyde, 0.1M sodium cacodylate and fix 2 was 1% osmium tetroxide, 0.1M sodium cacodylate. After EtOH dehydration samples were prepared using a Leica CPD300 critical point dryer, sputter coated with Au/Pd, using an Emitech 575X sputter coater, and examined in a FEI Quanta 200FEG SEM.

All *krt4:KalTA4-ER*^*t2*^ or *krt19:KalTA4-ER*^*t2*^ microinjected larvae were between 5 and 7dpf, Tg*(kita:Gal4;UAS:HRAS*^*G12V*^*-GFP)* larvae were 10dpf ([Figure 2](#fig2){ref-type="fig"}F) and 16dpf ([Figure 2](#fig2){ref-type="fig"}Aii)

### Confocal imaging {#sec3.4.8}

Larvae were mounted on their sides in 1.0% low-melting agarose (Sigma), in a glass-bottomed dish, filled with Danieau's buffer containing 0.01 mg/ml tricaine. Imaging was performed using a Leica TCS SP8 AOBS confocal laser scanning microscope attached to a Leica DMi8 inverted or a Leica DM6000 upright epifluorescence microscope using a 20x or 63x glycerol lens. Movies were exported from Volocity (PerkinElmer) as QuickTime movies using the Sorenson3 video compressor. For 3D reconstructions, imaging data were processed using either IMARIS software (Bitplane) or Volocity. Figures were prepared using Adobe Photoshop and Adobe Illustrator. Tracking of neutrophils was done using the Manual Tracking plugin from ImageJ.

### EdU Labeling {#sec3.4.9}

Cell proliferation was assessed using the Click-iT Plus EdU Alexa Fluor 647 Imaging Kit (Life Technologies, C10640). Larvae were injected into the yolk with 0.5nl of 10mM EdU (5-ethynyl-2′-deoxyuridine, a nucleoside analog of thymidine) and incubated for 2.5 hours at 28.5°C. After a 30-min fixation with 4% paraformaldehyde (PFA) at room temperature (RT), larvae were permeabilized in PBS containing 0.5% Triton X-100 (PBST), washed and blocked with PBST containing 3% (w/v) Bovine Serum Albumin for 1 hour at RT. Larvae were then incubated with the Click-it Plus reaction cocktail containing Alexa Fluor picolyl azide 647 for 30 min at RT and later subjected to whole-mount immunofluorescence staining as described below. For eGFP immunostaining, larvae were washed in PBST 3 times for 15 min and re-blocked with PBST containing 5% (v/v) goat serum, 3% (w/v) Bovine Serum Albumin for 2 hours at room temperature, before an over-night incubation at 4°C with rabbit monoclonal anti-GFP antibody (1:200) (2956, Cell Signaling Technology). After 10 × 15-min PBST washes, larvae were incubated in Alexa Fluor 488 Goat anti-Rabbit secondary antibody (1:250) (A-11008, Invitrogen) for 2 hours at room temperature and washed again in PBST 10 times. Stained larvae were stored at 4°C in a glycerol based antifadent mountant (AF1, CitiFluor).

### Immunofluorescent co-staining {#sec3.4.10}

5 dpf Tg(krt19:col 1α2-GFP) larvae were fixed with 2.5% PFA in PBS. After blocking with 5% goat serum in PBST, fixed larvae and primary antibodies to GFP and to collagen IV were incubated together (1:200). After extensive washing in multiple changes of PBST, larvae were incubated with Alexa Fluor 488 goat anti-mouse and Alexa Fluor 546 goat anti-rabbit secondary antibodies (1:500). After further PBST washes larvae were mounted in 1.5% agarose and imaged by confocal microscopy as above. Image analysis was performed using Fiji software.

Quantification and Statistical Analysis {#sec3.5}
---------------------------------------

Statistical analyses were performed using Prism (GraphPad). Data were confirmed to be normally distributed via d'Agostino--Pearson test or Shapiro--Wilk test prior to further comparisons and an unpaired two-tailed Student's t test or Wilcoxon-Mann-Whitney was used accordingly. Column scatter-plots show the mean ± SEM of all the individual data from repeated experiments or from a representative experiment as indicated in the figure legend. Significance values: ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.001, ^∗∗∗^p ≤ 0.0001.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S4 and Table S1Document S2. Article plus Supplemental Information

We thank Laura Ward for her help generating the Tg(*6xUAS:mCherry-HRASG12V*) zebrafish line, David Gurevich for technical assistance with the wounding experiments, and Thomas Ramenanzi for generating the *krtt1c19e:KalTAER*^*T2*^*-mlc:eGFP* construct. We thank all members of P.M.'s and Rebecca Richardson's labs for helpful discussions. We also thank Stephen Cross (funded by EBI, Wellcome Trust ISSF Award) and the team of the Wolfson Bioimaging Facility (Bristol, UK) for their help with imaging and image analysis. Finally, thanks to Giles Cory for editing text and drawing our Graphical Abstract. This work was funded by a CRUK Program Grant (C20590/A15936 to P.M.), a Wellcome Trust Investigator Award (097791/Z/11/Z to P.M.), and a Wellcome Trust Sir Henry Dale Fellowship (100104/Z/12/Z to Y.F.).

Author Contributions {#sec4}
====================

M.C.W.v.d.B., L.M.-M., and J.M. designed and performed the experiments; D.C. provided expert technical support with TEM; I.R.B. performed the EDU experiment and made the *pTol2-UAS:RAS*^*G12V*^*-mCherry;cry:CFP* construct; and M.C.W.v.d.B., L.M.-M., Y.F., and P.M. designed the study and wrote the manuscript.

Declaration of Interests {#sec5}
========================

The authors declare no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.celrep.2019.05.029>.

[^1]: These authors contributed equally

[^2]: Lead Contact
